GSK plc (NYSE: GSK) announced headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase 3 trial evaluating belantamab mafodotin as a second-line treatment for ...

GSK (NYSE:GSK) reported on Thursday positive ... The drugmaker had earlier reported positive efficacy results from DREAMM-7, another phase III head-to-head trial evaluating belantamab mafodotin ...

GSK is hoping to leapfrog Blenrep into earlier-line therapy with the DREAMM-7 and DREAMM-8 data, and said it is looking forward to discussing the data with regulators, saying the drug could ...

Now, the new data suggests GSK could start to get it at least partially back on track, with some analysts predicting $1.5 billion or more in sales if approved on the strength of the DREAMM-7 and ...

GSK is delivering consistent financial performance ... neurotox, etc. And the DREAMM-7 and DREAMM-8 studies have been well received. I think the critical thing here is really supporting physicians ...

(Alliance News) - GSK PLC on Tuesday said its Blenrep cancer ... "The application is based on interim results from the DREAMM-7 and DREAMM-8 phase III trials, which both met their primary ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK ...

GSK is on track to achieve its guidance for 2024, with its Q3 2024 and 9m 2024 results today. Explore more details here.

which GSK said "reflects the high unmet medical need and ensures priority NDA review in multiple myeloma". The regulatory submission was supported by results from the DREAMM-7 and DREAMM-8 phase ...

LONDON, Oct 7 (Reuters) - Pfizer (PFE.N), opens new tab on Monday won a bid in a London court to invalidate two of GSK's (GSK.L), opens new tab patents relating to a respiratory syncytial virus ...

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 1.19% to 8,229.99. Supported ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...